AI-Enabled Medical Imaging Solutions Market Report 2026

The ai-enabled medical imaging solutions market size has grown exponentially in recent years. It will grow from $2.9 billion in 2025 to $3.8 billion in 2026 at a compound annual growth rate (CAGR) of 31.2%. The growth in the historic period can be attributed to limited adoption of ai in medical imaging, reliance on conventional imaging analysis, shortage of trained radiologists, increasing incidence of chronic diseases, early investments in imaging infrastructure.

The ai-enabled medical imaging solutions market size is expected to see exponential growth in the next few years. It will grow to $11.23 billion in 2030 at a compound annual growth rate (CAGR) of 31.1%. The growth in the forecast period can be attributed to advancements in deep learning and computer vision, growth of personalized diagnostics, rising integration of ai with hospital information systems, increasing healthcare digitization initiatives, expansion of ai-enabled imaging in emerging markets. Major trends in the forecast period include increasing adoption of AI-based diagnostic support tools, rising use of AI-enhanced imaging devices in hospitals, expansion of multimodality imaging systems, growing demand for workflow and management solutions, enhanced accuracy and efficiency in clinical decision-making.

The growing prevalence of chronic disorders is expected to drive the expansion of the AI-enabled medical imaging solutions market in the coming years. Chronic disorders, or chronic illnesses, are medical conditions that persist for more than three months, including cancer, diabetes, heart disease, arthritis, chronic obstructive pulmonary disease, asthma, and autoimmune diseases. AI-enabled medical imaging accelerates the early detection of chronic illnesses by analyzing complex imaging data, enabling faster identification of abnormalities and timely intervention to improve patient outcomes. For instance, in September 2023, a report by the World Health Organization (WHO), a Switzerland-based specialized UN agency, indicated that noncommunicable diseases (NCDs) are responsible for 41 million deaths annually, accounting for 74% of all global deaths. Of these, 17 million people die from an NCD before the age of 70, with 86% of these premature deaths occurring in low- and middle-income countries. Cardiovascular diseases lead with 17.9 million deaths per year, followed by chronic respiratory diseases (4.1 million), cancers (9.3 million), and diabetes (2 million, including deaths from diabetes-related kidney disease). Therefore, the increasing prevalence of chronic disorders is fueling the growth of the AI-enabled medical imaging solutions market.

Major companies operating in the AI-enabled medical imaging solutions market are focusing on AI-enhanced image reconstruction, such as deep learning reconstruction, to deliver advanced technologies that improve diagnostic capabilities while maintaining patient comfort. Deep learning reconstruction (DLR) is a medical imaging technique that enhances image quality using deep learning algorithms. For instance, in November 2023, Canon Medical Systems USA Inc., a U.S.-based provider of imaging solutions, launched the Precise IQ Engine. The Precise IQ Engine is a high-resolution deep learning reconstruction system for magnetic resonance imaging, powered by Altivity, an innovative AI approach that leverages smart technologies to achieve superior quality, insight, and value. PIQE improves matrix size, reduces noise, and produces clear anatomical images, elevating MR imaging standards. The PIQE system generates high-spatial-resolution images from low-resolution scans while maintaining image quality and minimizing ringing artifacts.

In February 2023, GE HealthCare Technologies, Inc., a U.S.-based medical technology company specializing in imaging solutions, acquired Caption Health, Inc. for an undisclosed amount. This acquisition strengthens GE HealthCare's ultrasound business by incorporating AI-enabled image guidance into its ultrasound device portfolio. Caption Health, Inc. is a U.S.-based medical technology company specializing in AI-driven ultrasound guidance software.

Major companies operating in the ai-enabled medical imaging solutions market are Siemens AG, GE HealthCare Technologies, Inc, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Agfa-Gevaert N.V., Carestream Health, Aidoc Medical, Arterys Inc., icometrix, Riverain Technologies, iCAD Inc., Butterfly Network Inc, Subtle Medical, ContextVision AB, DiA Imaging Analysis Ltd, MaxQ AI Ltd, Qview Medical Inc, RADLogics Inc, Ziosoft, SyntheticMR, Beijing Infervision Technology Co. Ltd., NVIDIA Corporation, IBM Corporation, Nuance Communications Inc, EnvoyAI.

North America was the largest region in the AI-enabled medical imaging market in 2025. The regions covered in the ai-enabled medical imaging solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ai-enabled medical imaging solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the ai-enabled medical imaging solutions market by raising costs for imported imaging sensors, detectors, and ai-enabled hardware components. Segments such as ai-enhanced imaging devices and workstations are most affected, particularly in asia-pacific regions like china and india that are key manufacturing hubs. Tariffs have led to higher production costs and procurement delays but have also encouraged local manufacturing, innovation in cost-efficient imaging solutions, and development of regional supply chains.

The ai-enabled medical imaging solutions market research report is one of a series of new reports that provides ai-enabled medical imaging solutions market statistics, including ai-enabled medical imaging solutions industry global market size, regional shares, competitors with a ai-enabled medical imaging solutions market share, detailed ai-enabled medical imaging solutions market segments, market trends and opportunities, and any further data you may need to thrive in the ai-enabled medical imaging solutions industry. This ai-enabled medical imaging solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

AI-enabled medical imaging solutions include a variety of technologies that apply artificial intelligence (AI) in medical imaging to enhance the accuracy, efficiency, and personalization of diagnosis and treatment. These solutions support better clinical decision-making, help address healthcare workforce shortages, and enable the expansion of therapeutic applications.

The primary products of AI-enabled medical imaging solutions are software and hardware. Software consists of data, programs, or instructions that operate machines and perform specific functions, and AI-integrated medical imaging systems have significant potential to improve overall patient care while increasing diagnostic accuracy and efficiency. The imaging modalities include computed tomography (CT), magnetic resonance (MR), X-ray, ultrasound, mammography, multimodality imaging systems, and other modalities, integrated with technologies such as deep learning, natural language processing (NLP), computer vision, and others. These solutions are applied in areas such as breast imaging, respiratory and pulmonary care, neurology, orthopedics, and more. The industry verticals include hospitals and healthcare providers, patients, pharmaceutical and biotechnology companies, healthcare payers, and others.

The AI-enabled medical imaging solutions market consists of revenues earned by entities by providing services such as monitoring patient care, computer-aided diagnosis (CAD), image reconstruction, automated tumor detection, and cardiac imaging analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI-enabled medical imaging solutions market also includes sales of high-performance computing (HPC) systems, neuroimaging devices, gastrointestinal imaging products, and image segmentation tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.